Neuland Laboratories Limited (NEULANDLAB.NS)
INR 11501.75
(1.57%)
INR 11501.75
(1.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.24 Billion INR | -12.02% |
| 2022 | 5.77 Billion INR | 55.3% |
| 2021 | 3.71 Billion INR | 1.71% |
| 2020 | 3.65 Billion INR | 30.58% |
| 2019 | 2.79 Billion INR | 38.03% |
| 2018 | 2.02 Billion INR | 5.14% |
| 2017 | 1.92 Billion INR | -21.84% |
| 2016 | 2.46 Billion INR | 27.21% |
| 2015 | 1.94 Billion INR | 17.52% |
| 2014 | 1.65 Billion INR | -3.29% |
| 2013 | 1.7 Billion INR | 19.26% |
| 2012 | 1.43 Billion INR | 14.22% |
| 2011 | 1.25 Billion INR | 55.29% |
| 2010 | 806.99 Million INR | 33.0% |
| 2009 | 606.76 Million INR | -0.05% |
| 2008 | 607.07 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.37 Billion INR | 8.81% |
| 2023 Q2 | 2.26 Billion INR | 26.08% |
| 2023 Q1 | 1.79 Billion INR | -9.59% |
| 2023 Q4 | 1.26 Billion INR | -41.17% |
| 2023 FY | 5.08 Billion INR | -12.02% |
| 2023 Q3 | 2.14 Billion INR | -5.28% |
| 2022 Q4 | 1.98 Billion INR | 52.84% |
| 2022 Q2 | 1.47 Billion INR | 45.07% |
| 2022 FY | 5.77 Billion INR | 55.3% |
| 2022 Q1 | 1.01 Billion INR | 26.9% |
| 2022 Q3 | 1.29 Billion INR | -11.99% |
| 2021 Q1 | 840.68 Million INR | -4.99% |
| 2021 FY | 3.71 Billion INR | 1.71% |
| 2021 Q3 | 964.75 Million INR | -13.19% |
| 2021 Q4 | 801.28 Million INR | -16.94% |
| 2021 Q2 | 1.11 Billion INR | 32.19% |
| 2020 Q2 | 934.93 Million INR | 15.63% |
| 2020 FY | 3.65 Billion INR | 30.58% |
| 2020 Q4 | 884.82 Million INR | -13.87% |
| 2020 Q3 | 1.02 Billion INR | 9.88% |
| 2020 Q1 | 808.56 Million INR | 11.89% |
| 2019 Q3 | 742.44 Million INR | 2.78% |
| 2019 FY | 2.79 Billion INR | 38.03% |
| 2019 Q4 | 722.64 Million INR | -2.67% |
| 2019 Q2 | 722.36 Million INR | 18.0% |
| 2019 Q1 | 612.17 Million INR | 51.33% |
| 2018 Q3 | 587.28 Million INR | 7.53% |
| 2018 Q2 | 546.17 Million INR | 11.41% |
| 2018 Q1 | 490.24 Million INR | 0.0% |
| 2018 FY | 2.02 Billion INR | 5.14% |
| 2018 Q4 | 404.53 Million INR | -31.12% |
| 2017 FY | 1.92 Billion INR | -21.84% |
| 2016 Q4 | 649.08 Million INR | -2.26% |
| 2016 Q3 | 664.1 Million INR | 24.08% |
| 2016 Q2 | 535.24 Million INR | -6.09% |
| 2016 FY | 2.46 Billion INR | 27.21% |
| 2016 Q1 | 569.94 Million INR | 0.0% |
| 2015 FY | 1.94 Billion INR | 17.52% |
| 2014 FY | 1.65 Billion INR | -3.29% |
| 2013 FY | 1.7 Billion INR | 19.26% |
| 2012 FY | 1.43 Billion INR | 14.22% |
| 2011 FY | 1.25 Billion INR | 55.29% |
| 2010 FY | 806.99 Million INR | 33.0% |
| 2009 FY | 606.76 Million INR | -0.05% |
| 2008 FY | 607.07 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eris Lifesciences Limited | 10.42 Billion INR | 20.898% |
| Shilpa Medicare Limited | 3.56 Billion INR | -131.557% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 598.088% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 45.947% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -7197.099% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -41.44% |
| Alkem Laboratories Limited | 52.29 Billion INR | 84.229% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 69.202% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -32.544% |
| Divi's Laboratories Limited | 32.44 Billion INR | 74.575% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -1724.125% |
| Bal Pharma Limited | 770.19 Million INR | -970.877% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 92.471% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -123.19% |
| Brooks Laboratories Limited | 65.62 Million INR | -12469.092% |
| FDC Limited | 6.58 Billion INR | -25.229% |
| Granules India Limited | 16.79 Billion INR | 50.904% |
| Hester Biosciences Limited | 1.27 Billion INR | -547.575% |
| Ind-Swift Limited | 2.17 Billion INR | -279.642% |
| Ipca Laboratories Limited | 48.58 Billion INR | 83.024% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -1163.862% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 58.011% |
| Laurus Labs Limited | 15.44 Billion INR | 46.611% |
| Medico Remedies Limited | 262.14 Million INR | -3046.301% |
| Morepen Laboratories Limited | 6.16 Billion INR | -33.866% |
| Orchid Pharma Limited | 2.32 Billion INR | -255.464% |
| Vaishali Pharma Limited | 90.32 Million INR | -9031.493% |
| Sequent Scientific Limited | 2.97 Billion INR | -176.891% |
| Sigachi Industries Limited | 2 Billion INR | -311.922% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -100.031% |
| Valiant Laboratories Limited | 138.02 Million INR | -5875.438% |
| Windlas Biotech Limited | 1.33 Billion INR | -516.062% |
| ZIM Laboratories Limited | 1.26 Billion INR | -550.556% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 93.413% |
| Aarti Drugs Limited | 8.31 Billion INR | 0.822% |
| Ajanta Pharma Limited | 21.06 Billion INR | 60.844% |
| Alembic Limited | 1 Billion INR | -724.696% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -293.873% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -460.389% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -65646.018% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 10.413% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 94.959% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 33.662% |
| Hikal Limited | 5.95 Billion INR | -38.433% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -99.55% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -1229.274% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -1093.276% |
| Medicamen Biotech Limited | 495.49 Million INR | -1564.565% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -71.0% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -1458.737% |
| RPG Life Sciences Limited | 2.48 Billion INR | -232.172% |
| Unichem Laboratories Limited | 4.86 Billion INR | -69.537% |
| Venus Remedies Limited | 2.18 Billion INR | -277.893% |
| Wanbury Limited | 1.73 Billion INR | -376.577% |
| Wockhardt Limited | 7.72 Billion INR | -6.837% |
| Innova Captab Limited | 3.46 Billion INR | -138.071% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -42.662% |
| Themis Medicare Limited | 2.42 Billion INR | -240.819% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -74.776% |
| Mankind Pharma Limited | 42.19 Billion INR | 80.454% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 88.105% |
| Sakar Healthcare Limited | 699.58 Million INR | -1078.962% |
| Albert David Limited | 1.4 Billion INR | -485.748% |
| Lupin Limited | 125.09 Billion INR | 93.407% |
| Gufic Biosciences Limited | 4.07 Billion INR | -102.464% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 96.809% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -337.118% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -1374.137% |
| Piramal Enterprises Limited | 8.04 Billion INR | -2.543% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 82.36% |
| NATCO Pharma Limited | 25.73 Billion INR | 67.952% |
| Suven Life Sciences Limited | -200.79 Million INR | 4207.55% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 7684.428% |
| Strides Pharma Science Limited | 14.38 Billion INR | 42.676% |
| Indoco Remedies Limited | 8.04 Billion INR | -2.547% |
| Alpa Laboratories Limited | 188.89 Million INR | -4266.361% |
| Lasa Supergenerics Limited | 121.02 Million INR | -6714.706% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -2009.065% |